Inspection History
Synexus people know what they are doing, and the large regulatory bodies seem to agree.
Synexus has been inspected twice by the FDA with no significant outcome in either case. Again, there was no outcome in 2005 when the UK's MHRA audited the company.
We are also proud of our 150 staff trained in Good Clinical Practice.
Further, all planning and and internal monitoring is done centrally, with one contact and one contract, making for less work for the sponsor company.
All Synexus data is thoroughly checked internally before it goes to sponsor, meaning less CRFs for the drug company, saving them time and money.
Everyone at Synexus goes out of their way to make sure every process is executed without compromise.